Clinical Research

What is Clinical Research?

A clinical trial is a research program or study where patients volunteer to evaluate a new medical treatment, drug, or device. The purpose of clinical trials is to find new and improved methods of treating, preventing, screening for, and diagnosing different diseases. Clinical trials make it possible to apply the latest scientific and technological advances to patient care.

Benefits of Clinical Research

  • Clinical Research provides study medications, medical monitoring, and assessments at no cost to qualifying candidates

  • Research stipends often provided for qualifying patients
  • Provide access to alternative treatments if standard of care treatments have failed

  • Help the medical communities and researchers expand medical knowledge and awareness to help future generations

  • Option for patients who have no medical insurance or prescription coverage

Non-Alcoholic Steatohepatitis (NASH) or Fatty Liver Disease

Non-alcoholic fatty liver disease affects 1/3rd of the US population. Five to ten percent of those advance into what is known as non-alcoholic steatohepatitis (NASH). It is the number one cause of cirrhosis of liver and liver transplantation. Risks factors for NASH include obesity, hyperlipidemia, and insulin resistance/ diabetes. Up until now, there was no FDA approved medication to treat this condition.

 

If you are suffering from advanced fatty liver disease (NASH), please contact us to see if you are eligible for one of our clinical research studies. 

Inflammatory Bowel Disease (IBD)

Inflammatory bowel diseases (IBD), which include Crohn’s disease and ulcerative colitis, affect as many as 3 million Americans, most of whom are diagnosed before age 35. As the lining of the intestine becomes inflamed, it loses its ability to adequately process food or absorb water, resulting in loose stools (diarrhea), abdominal pain, rectal bleeding, weight loss, and an urgent need to move bowels. IBD is a chronic, life-long illness. It is common for individuals to go through periods when the disease is quiet with few or no symptoms (remission), alternating with times when the disease is active and causing symptoms (flares). Greater research is needed to find a cure and provide additional treatment options for individuals who experience flares while taking currently available medications. If you are looking for novel treatment options for IBD contact us to see if you are eligible for our clinical research studies.

Registry and Clinical Device Trials

In addition to our drug trials, we offer a range of other research studies for relatively healthy patients. These trials include validating new medical devices for colonoscopies and developing colorectal cancer blood screenings. If you are scheduled for a colonoscopy and are interested in hearing more about what research trails you may qualify for, please do not hesitate to reach out to our research team. 

Contact our research department at:

540-206-2899
vshvygina@GastroenterologyEndoscopy.onmicrosoft.com

540-510-3337
ljennewein@roanokegastro.onmicrosoft.com

540-685-4236
ccrawford@GastroenterologyEndoscopy.onmicrosoft.com